Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks

Autor: Stefan P. M. Smorenburg, Rutger J. Lely, Bas-Jeroen van Kelckhoven, Erik G. Vermeulen, Kak Khee Yeung, Rombout R. Kruse, Martin Kraai, Chrit M. Stassen, Michael J. Jacobs, Arjan W. J. Hoksbergen

Publikováno v: Journal of Endovascular Therapy. SAGE Publications Inc.
Journal of Endovascular Therapy. International Society of Endovascular Specialists
Smorenburg, S P M, Lely, R J, Kelckhoven, B-J V, Vermeulen, E G, Yeung, K K, Kruse, R R, Kraai, M, Stassen, C M, Jacobs, M J & Hoksbergen, A W J 2023, ' Initial Clinical Experience With AneuFix Injectable Biocompatible Elastomer for Translumbar Embolization of Type 2 Endoleaks ', Journal of Endovascular Therapy . https://doi.org/10.1177/15266028231165731

Purpose: The aim of this study was to assess the initial experience, technical success, and clinical benefit of AneuFix (TripleMed, Geleen, the Netherlands), a novel biocompatible and non-inflammatory elastomer that is directly injected into the aneu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b807570319c43d79d3196b339787fb6e
https://cris.maastrichtuniversity.nl/en/publications/ea42c399-be22-4ec9-8414-6561221058eb